ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.681,60
-0,24%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
0,00%
Euro vs US Dollar
1,08435
-0,22%
Bitcoin
66.317,23
1,65%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Stemline Therapeutics Inc (STML)

  7. Stemline Therapeutics Inc (STML) News

STML

Stemline Therapeutics (STML)

Stemline Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:STML
DatumZeitQuelleÜberschriftSymbolFirma
12/02/202122h18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:STMLStemline Therapeutics Inc
22/06/202015h52Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:STMLStemline Therapeutics Inc
17/06/202012h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
17/06/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
17/06/202012h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h10Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h50Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h48Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202016h20Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:STMLStemline Therapeutics Inc
10/06/202016h05Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STMLStemline Therapeutics Inc
10/06/202016h05Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
10/06/202015h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STMLStemline Therapeutics Inc
04/06/202023h00Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
02/06/202014h37Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:STML

Kürzlich von Ihnen besucht

TSXV
CERT
Cerrado Gold
AQSE
PXEN.GB
Prospex Energy
NYSE
HQL
abrdn Life Sciences Inve...
NYSE
VSCO
Victoria's Secret
BITMOT
882360
Intsanpaolo Tf 1,4% Fb31...
USOTC
FRDSF
4DS Memory (PK)
LBNK
SAITANOBIUSDT
Saitanobi
NYSE
NIC
Nicolet Bankshares
EU
ESGF4
Euronext France ESG Lead...
LBNK
ENTUSDT
Entropy
COIN
HDNETH
ASX
SSMN
LSE
0MI1
AMEX
PTEST
Test
NASDAQ
ANDW
USOTC
GCCFF
Golden Cariboo Resources (PK)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten